BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 22833926)

  • 1. Therapeutic delivery opportunities, obstacles and applications for cell-penetrating peptides.
    Lindberg S; Copolovici DM; Langel U
    Ther Deliv; 2011 Jan; 2(1):71-82. PubMed ID: 22833926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A survey on "Trojan Horse" peptides: opportunities, issues and controlled entry to "Troy".
    Shi NQ; Qi XR; Xiang B; Zhang Y
    J Control Release; 2014 Nov; 194():53-70. PubMed ID: 25151981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell-penetrating peptides: strategies for anticancer treatment.
    Raucher D; Ryu JS
    Trends Mol Med; 2015 Sep; 21(9):560-70. PubMed ID: 26186888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanocarriers Conjugated with Cell Penetrating Peptides: New Trojan Horses by Modern Ulysses.
    Zappavigna S; Misso G; Falanga A; Perillo E; Novellino E; Galdiero M; Grieco P; Caraglia M; Galdiero S
    Curr Pharm Biotechnol; 2016; 17(8):700-22. PubMed ID: 27087493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell penetrating peptides for tumor targeting.
    Choi YS; Lee JY; Suh JS; Lee SJ; Yang VC; Chung CP; Park YJ
    Curr Pharm Biotechnol; 2011 Aug; 12(8):1166-82. PubMed ID: 21470141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell penetrating peptides: efficient vectors for delivery of nanoparticles, nanocarriers, therapeutic and diagnostic molecules.
    Farkhani SM; Valizadeh A; Karami H; Mohammadi S; Sohrabi N; Badrzadeh F
    Peptides; 2014 Jul; 57():78-94. PubMed ID: 24795041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo biodistribution and efficacy of peptide mediated delivery.
    Järver P; Mäger I; Langel Ü
    Trends Pharmacol Sci; 2010 Nov; 31(11):528-35. PubMed ID: 20828841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Challenge to overcome current limitations of cell-penetrating peptides.
    Kim GC; Cheon DH; Lee Y
    Biochim Biophys Acta Proteins Proteom; 2021 Apr; 1869(4):140604. PubMed ID: 33453413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cell-type specificity and endosomal escape of cell-penetrating peptides.
    Feng J; Tang L
    Curr Pharm Des; 2015; 21(10):1351-6. PubMed ID: 25341672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell penetrating peptides: the potent multi-cargo intracellular carriers.
    Kardani K; Milani A; H Shabani S; Bolhassani A
    Expert Opin Drug Deliv; 2019 Nov; 16(11):1227-1258. PubMed ID: 31583914
    [No Abstract]   [Full Text] [Related]  

  • 11. Recent advances of anti-cancer therapies including the use of cell-penetrating peptides.
    Klimpel A; Lützenburg T; Neundorf I
    Curr Opin Pharmacol; 2019 Aug; 47():8-13. PubMed ID: 30771730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PEGylation and Cell-Penetrating Peptides: Glimpse into the Past and Prospects in the Future.
    Kumar S; Singh D; Kumari P; Malik RS; Poonam ; Parang K; Tiwari RK
    Curr Top Med Chem; 2020; 20(5):337-348. PubMed ID: 31994461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Harnessing the capacity of cell-penetrating peptides for drug delivery to the central nervous system.
    Kang T; Gao X; Chen J
    Curr Pharm Biotechnol; 2014; 15(3):220-30. PubMed ID: 24938893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclic Cell-Penetrating Peptides as Efficient Intracellular Drug Delivery Tools.
    Park SE; Sajid MI; Parang K; Tiwari RK
    Mol Pharm; 2019 Sep; 16(9):3727-3743. PubMed ID: 31329448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An opportunistic route to success: Towards a change of paradigm to fully exploit the potential of cell-penetrating peptides.
    Collado Camps E; Brock R
    Bioorg Med Chem; 2018 Jun; 26(10):2780-2787. PubMed ID: 29157727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro and in vivo delivery of therapeutic proteins using cell penetrating peptides.
    Bolhassani A; Jafarzade BS; Mardani G
    Peptides; 2017 Jan; 87():50-63. PubMed ID: 27887988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent in vivo advances in cell-penetrating peptide-assisted drug delivery.
    Kurrikoff K; Gestin M; Langel Ü
    Expert Opin Drug Deliv; 2016; 13(3):373-87. PubMed ID: 26634750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peptide cargo administration: current state and applications.
    Rohira H; Arora A; Kaur P; Chugh A
    Appl Microbiol Biotechnol; 2023 May; 107(10):3153-3181. PubMed ID: 37052636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peptide-mediated delivery: an overview of pathways for efficient internalization.
    Pae J; Pooga M
    Ther Deliv; 2014 Nov; 5(11):1203-22. PubMed ID: 25491671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enzyme-triggered, cell penetrating peptide-mediated delivery of anti-tumor agents.
    He H; Sun L; Ye J; Liu E; Chen S; Liang Q; Shin MC; Yang VC
    J Control Release; 2016 Oct; 240():67-76. PubMed ID: 26514292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.